U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757542) titled 'Safety Assessment of H2 Inhalation in Patients With Mild Cognitive Impairment' on July 29.
Brief Summary: An open-label, one-arm, single-center clinical study tested safety and efficacy of one hour daily dosage of H2 gas in a form of inhalation. Dosage is administered during morning hours every working day according to detailed instructions to study participants.
Primary objective: To verify the safety of hydrogen gas inhalation on a sample of patients with mild cognitive impairment (according to the objective opinion of the physician) and diagnosed mild to moderate form of dementia, as well as to verify cognitive abilities via tes...